Tetanus prevention after injury: study of siltartoxatug
Part of Infections clinical trials.
This study compares a new tetanus shot (siltartoxatug) with standard tetanus treatments to see if it works as well. It is for people aged 18 and older who need tetanus protection after an injury.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are getting a tetanus shot with siltartoxatug, or another tetanus treatment like human tetanus immunoglobulin (HTIG), tetanus antitoxin (TAT), or a special fragment of equine antibody (F(ab')₂).
- You are receiving or will receive standard wound care.
- You (or your legal representative) can sign a consent form to join the study.
- You do not have a life expectancy less than 3 months.
- You do not have severe cognitive issues or other conditions that would make it hard to check for tetanus, and you are not in another treatment trial (observational studies are okay).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This registry collects information on people who receive the study drug Siltartoxatug to prevent tetanus after an injury. It helps researchers learn more about how the drug works in real-world use.
This study tests an injection that may help prevent tetanus in people who have had a high-risk exposure, like a deep or dirty wound. It aims to see if the injection is safe and effective for protecting against tetanus.
This trial tests a new medicine made from antibodies that target tetanus toxin. It may help protect people from tetanus without needing a vaccine.
This study checks how long your body's protection from the tetanus vaccine lasts. It follows up with people who already got the vaccine in an earlier study to see if their immunity is still strong years later.
This study checks if a simple saliva test can detect tetanus protection, which could replace blood tests. It includes healthy children, young adults, pregnant women, and adults with certain health conditions.
This study tests a new microneedle patch that delivers a tetanus booster vaccine through tiny needles in the skin, without a traditional shot. The patch is applied to the forearm, and the study checks its safety and how the body responds.
Hear when a new Tetanus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.